Bayer has inaugurated its Radiology Research & Development Hub in Bengaluru, marking a strategic milestone in its global innovation network. The hub will focus on AI, software, connectivity, and workflow solutions to advance next-generation diagnostic imaging and strengthen India’s role in Bayer’s worldwide R&D initiatives.
A Strategic Node in Bayer’s Global Network
The Bengaluru hub integrates with Bayer’s R&D centers in Pittsburgh, Berlin, and Sydney, enabling fast innovation cycles and seamless collaboration. It will enhance software, AI, and connectivity capabilities, providing scalable, customer-centric solutions for global diagnostic imaging.
“By combining India’s digital strengths with Bayer’s expertise, we aim to bring agile and scalable radiology solutions to global markets,” said Dr. Konstanze Diefenbach, SVP & Head of Radiology R&D, Bayer.
Focus Areas and Capabilities
The hub will concentrate on:
- Software development for contrast media injection systems
- Validation and verification of injection devices
- AI-powered innovation for imaging precision, workflow efficiency, and CT/CV/MR modalities
- Supporting Bayer’s AI Innovation Platform (AIIP) on Google Cloud for secure, scalable, regulatory-compliant AI applications
By integrating domain expertise with cutting-edge technology, the Bengaluru hub is positioned as a cornerstone for future-ready healthcare solutions.
Bengaluru: A Thriving Innovation Ecosystem
Bayer emphasizes Bengaluru’s combination of medical device expertise, AI talent, startups, and academic collaboration. This ecosystem enables Bayer to co-develop digital health solutions that are relevant both for India and global markets.
The hub will also support collaborations with academic institutions and startups, creating an innovation bridge between global R&D and India’s healthcare technology ecosystem.
Global Impact and Future Outlook
Over the next 3–5 years, the Bengaluru hub is expected to:
- Advance AI-enabled imaging, workflow automation, and connectivity solutions
- Sustain and enhance Bayer’s marketed medical devices
- Strengthen India’s role in global radiology R&D
- Deliver digital-first, patient-centric solutions at scale
Bayer’s Bengaluru Radiology Hub reflects the company’s commitment to innovation, collaboration, and shaping the future of diagnostic imaging worldwide.
Visit Our News section and follow us on LinkedIn and Twitter
Read more full news: Here
